{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:29:32Z","timestamp":1793276972715,"version":"4.5.0"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.3201\/eid3008.240019","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T03:09:39Z","timestamp":1722308979000},"source":"Crossref","is-referenced-by-count":29,"title":["Hepatitis B Virus Reactivation After Switch to Cabotegravir\/Rilpivirine in Patient with Low Hepatitis B Surface Antibody"],"prefix":"10.3201","volume":"30","author":[{"given":"Eisuke","family":"Adachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Sedohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Arizono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amato","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yotsuyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3008.240019-202407191126-R1","first-page":"1","article-title":"CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.","volume":"62","author":"Schillie","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid3008.240019-202407191126-R2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.jcmgh.2021.07.013","article-title":"Amino acid polymorphism in hepatitis B virus associated with functional cure.","volume":"12","author":"Honda","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"key-10.3201\/eid3008.240019-202407191126-R3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ijid.2008.08.018","article-title":"Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa.","volume":"13","author":"Firnhaber","year":"2009","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid3008.240019-202407191126-R4","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1053\/gast.1997.v113.pm9352871","article-title":"Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen.","volume":"113","author":"Dickson","year":"1997","journal-title":"Gastroenterology"},{"key":"key-10.3201\/eid3008.240019-202407191126-R5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12985-021-01706-w","article-title":"Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers.","volume":"18","author":"Kuhns","year":"2021","journal-title":"Virol J"},{"key":"key-10.3201\/eid3008.240019-202407191126-R6","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1128\/JCM.00366-07","article-title":"Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.","volume":"45","author":"Wong","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3008.240019-202407191126-R7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jmv.23183","article-title":"Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen.","volume":"84","author":"Ma","year":"2012","journal-title":"J Med Virol"},{"key":"key-10.3201\/eid3008.240019-202407191126-R8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/j.1440-1746.2010.06243.x","article-title":"Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management.","volume":"25","author":"Lubel","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"key-10.3201\/eid3008.240019-202407191126-R9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4161\/21645515.2014.994461","article-title":"A new vaccine escape mutant of hepatitis B virus causes occult infection.","volume":"11","author":"Ye","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid3008.240019-202407191126-R10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep4.1118","article-title":"HBV reactivation in allogeneic stem cell transplant recipients: Risk factors, outcome, and role of hepatitis B virus mutations.","volume":"1","author":"Anastasiou","year":"2017","journal-title":"Hepatol Commun"},{"key":"key-10.3201\/eid3008.240019-202407191126-R11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/v11090778","article-title":"Immune-escape hepatitis B virus mutations associated with viral reactivation upon immunosuppression.","volume":"11","author":"Lazarevic","year":"2019","journal-title":"Viruses"},{"key":"key-10.3201\/eid3008.240019-202407191126-R12","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/QAD.0000000000002941","article-title":"Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.","volume":"35","author":"Mican","year":"2021","journal-title":"AIDS"},{"key":"key-10.3201\/eid3008.240019-202407191126-R13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/QAI.0000000000003239","article-title":"Brief Report: Hepatitis B infection or reactivation after switch to 2-drug antiretroviral therapy: a case series, literature review, and management discussion.","volume":"94","author":"Vasishta","year":"2023","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key-10.3201\/eid3008.240019-202407191126-R14","doi-asserted-by":"crossref","unstructured":"Welford E, Yin J, Hill L, Wooten D. A case series of low-level HBV viremia after switching to long-acting injectable cabotegravir\/rilpivirine in patients with HIV, hepatitis B core antibody positivity, and hepatitis B surface antigen negativity. In: Abstracts of IDweek 2022; Washington, DC, USA; 2022 Oct 19\u201323. Abstract 1583. Arlington (VA): Infectious Diseases Society of America; 2022.","DOI":"10.1093\/ofid\/ofac492.106"},{"key":"key-10.3201\/eid3008.240019-202407191126-R15","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1093\/infdis\/jiw011","article-title":"ANRS HB EP03 CISOVAC Study Group. Vaccination against hepatitis B virus (HBV) in HIV-1\u2013infected patients with isolated anti-HBV core antibody: the ANRS HB EP03 CISOVAC prospective study.","volume":"213","author":"Piroth","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/8\/24-0019_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:38:28Z","timestamp":1732905508000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/8\/24-0019_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3008.240019","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}